Global Colorectal Cancer Epidemiology and Patient Flow Analysis - 2017

Global Colorectal Cancer Epidemiology and Patient Flow Analysis - 2017

  • January 2017 •
  • Report ID: 3895239 •
  • Format: PDF
Fore Pharma announced the results of its Colorectal Cancer patients study in a new report ‘Global Colorectal Cancer Epidemiology and Patient Flow Analysis - 2017’.

The report provides insights into Colorectal Cancer epidemiology, Colorectal Cancer diagnosed patients, and Colorectal Cancer treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Colorectal Cancer derived from epidemiological analysis, percentage of patients diagnosed with Colorectal Cancer, and percentage of patients treated with a therapy.

The study helps executives estimate Colorectal Cancer market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The report provides estimates and forecasts of Colorectal Cancer prevalence, Colorectal Cancer diagnosis rate, and Colorectal Cancer treatment rate for the period 2016 - 2025. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on interpretation and analysis of data collected from physicians via primary interviews, registries, scientific journals, literatures, government databases and other secondary sources.

Key Features of the Report:
- Colorectal Cancer Patient Flow
- Colorectal Cancer Prevalence
- Colorectal Cancer Diagnosed Patients
- Colorectal Cancer Treated Patients